NUVA.DE
Noratis AG [NUVA.DE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NUVA.DE Stock Summary
Top 10 Correlated ETFs
NUVA.DE
Top 10 Correlated Stocks
NUVA.DE
In the News
NUVA.DE Financial details
Company Rating
Sell
Market Cap
34.74M
Income
7.01M
Revenue
134.14M
Book val./share
15.95
Cash/share
2.33
Dividend
-
Dividend %
-
Employees
71
Optionable
No
Shortable
Yes
Earnings
29 Sep 2023
P/E
3.72
Forward P/E
-
PEG
-1.43
P/S
0.48
P/B
0.35
P/C
2.19
P/FCF
-1.23
Quick Ratio
0.35
Current Ratio
13.47
Debt / Equity
4.73
LT Debt / Equity
4.51
-
-
EPS (TTM)
1.35
EPS next Y
-
EPS next Q
-
EPS this Y
-13.19%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-9.27%
Revenue last 5Y
8.9%
Revenue Q/Q
92.2%
EPS Q/Q
-1234.38%
-
-
-
-
SMA20
-16.67%
SMA50
-28.57%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
2%
ROE
10%
ROC
0.05%
Gross Margin
29%
Oper. Margin
25%
Profit Margin
10%
Payout
32%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.2-9.815816
52W High
-43.33%
52W Low
+27.5%
RSI
41
Rel Volume
0.07
Avg Volume
1.42K
Volume
100
Perf Week
-0.97%
Perf Month
-12.07%
Perf Quarter
-11.3%
Perf Half Y
-16.39%
-
-
-
-
Beta
0.351
-
-
Volatility
0.09%, 0.4%
Prev Close
3.66%
Price
5.1
Change
3.66%
NUVA.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 15.58 | 19.46 | 6.66 | 14.21 | 16.52 | |
| Net income per share | 2.57 | 2.21 | 0.64 | 1.82 | 1.58 | |
| Operating cash flow per share | -23.85 | -5.58 | -22.53 | -14.57 | -7.81 | |
| Free cash flow per share | -23.92 | -5.61 | -22.54 | -14.59 | -7.85 | |
| Cash per share | 2.68 | 1.82 | 7.15 | 1.69 | 2.37 | |
| Book value per share | 13.67 | 13.4 | 16.97 | 15.54 | 16.61 | |
| Tangible book value per share | 13.72 | 13.45 | 17.07 | 15.62 | 16.69 | |
| Share holders equity per share | 13.67 | 13.4 | 16.97 | 15.54 | 16.61 | |
| Interest debt per share | 43.86 | 46.61 | 65.95 | 66.57 | 76.57 | |
| Market cap | 71.17M | 76.19M | 70.58M | 91.1M | 55.52M | |
| Enterprise value | 218.34M | 252.81M | 327.04M | 428.1M | 443.38M | |
| P/E ratio | 7.7 | 8.81 | 25.35 | 9.62 | 6.74 | |
| Price to sales ratio | 1.27 | 1 | 2.44 | 1.23 | 0.65 | |
| POCF ratio | -0.83 | -3.49 | -0.72 | -1.2 | -1.37 | |
| PFCF ratio | -0.83 | -3.48 | -0.72 | -1.2 | -1.36 | |
| P/B Ratio | 1.45 | 1.45 | 0.96 | 1.13 | 0.64 | |
| PTB ratio | 1.45 | 1.45 | 0.96 | 1.13 | 0.64 | |
| EV to sales | 3.89 | 3.32 | 11.29 | 5.79 | 5.16 | |
| Enterprise value over EBITDA | 13.23 | 16.4 | 40.65 | 25.92 | 32.43 | |
| EV to operating cash flow | -2.54 | -11.6 | -3.34 | -5.65 | -10.91 | |
| EV to free cash flow | -2.53 | -11.53 | -3.34 | -5.64 | -10.86 | |
| Earnings yield | 0.13 | 0.11 | 0.04 | 0.1 | 0.15 | |
| Free cash flow yield | -1.21 | -0.29 | -1.39 | -0.83 | -0.74 | |
| Debt to equity | 3.15 | 3.41 | 3.83 | 4.2 | 4.5 | |
| Debt to assets | 0.72 | 0.68 | 0.77 | 0.76 | 0.79 | |
| Net debt to EBITDA | 8.92 | 11.46 | 31.87 | 20.4 | 28.37 | |
| Current ratio | 8.11 | 8.93 | 39.13 | 4.07 | 13.3 | |
| Interest coverage | 5.48 | 4.12 | 1.81 | 2.49 | 1.42 | |
| Income quality | -9.29 | -2.64 | -35.19 | -8 | -4.94 | |
| Dividend Yield | 0.06 | 0.06 | 0.04 | 0.03 | 0.05 | |
| Payout ratio | 0.47 | 0.54 | 1.04 | 0.25 | 0.32 | |
| Sales general and administrative to revenue | 0.06 | 0 | 0.02 | 0.02 | 0.02 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0.01 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -1.37 | -0.29 | -0.17 | -0.24 | -0.38 | |
| Stock based compensation to revenue | 1.78 | 0 | 0 | 0 | 0 | |
| Graham number | 28.1 | 25.83 | 15.63 | 25.23 | 24.32 | |
| ROIC | 0.06 | 0.05 | 0.01 | 0.03 | 0.02 | |
| Return on tangible assets | 0.04 | 0.03 | 0.01 | 0.02 | 0.02 | |
| Graham Net | -13.49 | -18.69 | -21.71 | -27.64 | -31.79 | |
| Working capital | 184.84M | 229.75M | 356.64M | 327.81M | 437.98M | |
| Tangible asset value | 49.41M | 52.57M | 74.23M | 81.27M | 86.83M | |
| Net current asset value | 46.23M | 50.64M | 72.7M | 68.7M | 65.04M | |
| Invested capital | 3.15 | 3.41 | 3.83 | 4.2 | 4.5 | |
| Average receivables | 12.86M | 16.26M | 4.91M | 1.49M | 3.08M | |
| Average payables | 1.37M | 10.18M | 9.94M | 8.47M | 8.81M | |
| Average inventory | 137.94M | 209.91M | 288.33M | 378.84M | 439.5M | |
| Days sales outstanding | 156.43 | 40.6 | 17 | 8.09 | 19.23 | |
| Days payables outstanding | 20.26 | 122.5 | 36.32 | 112.25 | 12.31 | |
| Days of inventory on hand | 1.87K | 1.61K | 8.51K | 3.07K | 2.68K | |
| Receivables turnover | 2.33 | 8.99 | 21.47 | 45.12 | 18.98 | |
| Payables turnover | 18.02 | 2.98 | 10.05 | 3.25 | 29.64 | |
| Inventory turnover | 0.2 | 0.23 | 0.04 | 0.12 | 0.14 | |
| ROE | 0.19 | 0.17 | 0.04 | 0.12 | 0.1 | |
| Capex per share | -0.06 | -0.03 | -0.02 | -0.02 | -0.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 11.53 | 2.7 | 13.15 | 3.4 | 6.54 | |
| Net income per share | 1.4 | 0.42 | 1.52 | 0.06 | -0.65 | |
| Operating cash flow per share | -3.91 | -10.66 | 1.3 | -9.12 | 1.59 | |
| Free cash flow per share | -3.92 | -10.67 | 1.3 | -9.15 | 1.58 | |
| Cash per share | 1.54 | 1.69 | 2.16 | 2.37 | 2.33 | |
| Book value per share | 15.11 | 15.54 | 16.54 | 16.61 | 15.95 | |
| Tangible book value per share | 15.18 | 15.62 | 16.63 | 16.69 | 16.03 | |
| Share holders equity per share | 15.11 | 15.54 | 16.54 | 16.61 | 15.95 | |
| Interest debt per share | 56.2 | 65.98 | 67.69 | 75.73 | 77.18 | |
| Market cap | 99.64M | 91.1M | 73.52M | 55.52M | 45.06M | |
| Enterprise value | 380.98M | 428.11M | 410.16M | 443.38M | 426.61M | |
| P/E ratio | 3.41 | 10.49 | 2.32 | 46.57 | -3.32 | |
| Price to sales ratio | 1.66 | 6.5 | 1.07 | 3.14 | 1.32 | |
| POCF ratio | -4.9 | -1.64 | 10.83 | -1.17 | 5.46 | |
| PFCF ratio | -4.89 | -1.64 | 10.87 | -1.17 | 5.46 | |
| P/B Ratio | 1.27 | 1.13 | 0.85 | 0.64 | 0.54 | |
| PTB ratio | 1.27 | 1.13 | 0.85 | 0.64 | 0.54 | |
| EV to sales | 6.35 | 30.52 | 6 | 25.06 | 12.54 | |
| Enterprise value over EBITDA | 28.15 | 155.17 | 33.88 | 358.43 | 140.98 | |
| EV to operating cash flow | -18.75 | -7.72 | 60.43 | -9.35 | 51.67 | |
| EV to free cash flow | -18.7 | -7.71 | 60.64 | -9.32 | 51.74 | |
| Earnings yield | 0.07 | 0.02 | 0.11 | 0.01 | -0.08 | |
| Free cash flow yield | -0.2 | -0.61 | 0.09 | -0.86 | 0.18 | |
| Debt to equity | 3.68 | 4.2 | 4.04 | 4.5 | 4.73 | |
| Debt to assets | 0.77 | 0.76 | 0.78 | 0.79 | 0.81 | |
| Net debt to EBITDA | 20.79 | 122.15 | 27.81 | 313.55 | 126.09 | |
| Current ratio | 18.65 | 4.07 | 29.13 | 13.3 | 21.57 | |
| Interest coverage | 4.3 | 0.75 | 2.73 | 0.2 | 0.31 | |
| Income quality | -2.78 | -25.55 | 0.86 | -159.15 | -2.43 | |
| Dividend Yield | 0.02 | 0 | 0.04 | 0 | 0.31 | |
| Payout ratio | 0.33 | 0 | 0.33 | 0 | -4.16 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | -0.01 | 0 | |
| Capex to depreciation | -0.21 | -0.27 | -0.1 | -0.65 | -0.05 | |
| Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
| Graham number | 21.84 | 12.08 | 23.82 | 4.63 | 15.31 | |
| ROIC | 0.03 | 0 | 0.02 | 0 | 0 | |
| Return on tangible assets | 0.02 | 0 | 0.02 | 0 | -0.01 | |
| Graham Net | -20.39 | -27.64 | -26.72 | -31.79 | -31.75 | |
| Working capital | 354.43M | 327.81M | 411.86M | 437.98M | 441.94M | |
| Tangible asset value | 79.01M | 81.27M | 86.54M | 86.83M | 83.42M | |
| Net current asset value | 77.34M | 68.7M | 69.35M | 65.04M | 64.14M | |
| Invested capital | 3.68 | 4.2 | 4.04 | 4.5 | 4.73 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 1.17 | 10.52 | 1.72 | 23.04 | 3.87 | |
| Days payables outstanding | 4.13 | 188.44 | 4.68 | 18.58 | 5.63 | |
| Days of inventory on hand | 770.54 | 5.15K | 721.83 | 4.04K | 1.78K | |
| Receivables turnover | 76.93 | 8.56 | 52.3 | 3.91 | 23.25 | |
| Payables turnover | 21.78 | 0.48 | 19.22 | 4.84 | 15.98 | |
| Inventory turnover | 0.12 | 0.02 | 0.12 | 0.02 | 0.05 | |
| ROE | 0.09 | 0.03 | 0.09 | 0 | -0.04 | |
| Capex per share | -0.01 | -0.01 | 0 | -0.03 | 0 |
NUVA.DE Frequently Asked Questions
What is Noratis AG stock symbol ?
Noratis AG is a DE stock and trading under the symbol NUVA.DE
What is Noratis AG stock quote today ?
Noratis AG stock price is $5.1 today.
Is Noratis AG stock public?
Yes, Noratis AG is a publicly traded company.
Company Profile
- Volume Average 1.42K
- Market Capitalization 34.74M
- Employee 71
- CEO Mr. Igor Christian Bugarski
- Headquarters Eschborn,DE
- IPO Date 2017-06-30
-
Website
https://www.noratis.de 
Noratis AG invests in, develops, manages, and sells residential property portfolios in Germany. The company primarily focuses on a portfolio of apartments, residential areas, and housing estates. Noratis AG was founded in 2002 and is based in Eschborn, Germany.
